RIGVIR® is registered in the European Union member state Latvia in the Latvian State Agency of Medicines on April 29, 2004.
Since 2015 RIGVIR® is included in the national guidelines for the skin cancer and melanoma treatment. RIGVIR® is prescription medicine.

To receive a consultation and prescription, please contact:

International Virotherapy Center

Responsible service: Information center
Language for communication: ENG, RUS, LAT
Phone: +371 67 229 599
E-mail: info@virotherapy.eu
Website: www.virotherapy.eu

Central Office
International Virotherapy Center
Language for communication: ENG, RUS, LAT
Address: 9 Teātra street, LV–1050, Riga, Latvia
Website: www.virotherapy.eu